PTSD is a severe mental health challenge that emerges after experiencing or witnessing deeply traumatic events. Symptoms include recurrent and distressing memories, heightened alertness, and avoidance behaviors.
Early research suggests that ketamine may disrupt the reconsolidation of traumatic memories, helping to lessen their emotional charge.
Co-occurring depression is common in PTSD. Ketamine can swiftly combat these depressive symptoms, alleviating two major challenges concurrently.
The constant state of heightened alertness or “hyperarousal” can be mitigated with ketamine treatment, promoting improved sleep and reduced anxiety.
By impacting NMDA receptors, ketamine might help in recalibrating brain responses to distressing stimuli.
By modulating brain function, ketamine might help in regulating emotional reactions, reducing the intensity of responses to triggers.
Reduced symptoms through ketamine might make patients more receptive to psychotherapeutic interventions, enhancing overall treatment outcomes.
